Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periprocedural Normobaric Hyperoxia With Endovascular Therapy for Acute Ischemic Stroke 6-24 Hours After Last Known Well
NCT07717216Phase 3Not yet recruiting
- Sponsor
- Shandong Second Medical University
- Start
- Sep 2026
- Primary completion
- Sep 2029
01
Overview
A Phase 3 trial of oxygen in ischemic stroke, sponsored by Shandong Second Medical University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
oxygen
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07717216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07717216.